Device maker enters settlement for failing to disclose payments to physicians

May 8, 2009

Email This Post Print This Post

Medical device maker Synthes, Inc., based in West Chester, PA, entered into a settlement agreement with the New Jersey Attorney General (AG) to resolve allegations the company failed to disclose financial conflicts-of-interest among doctors who conducted clinical testing on its products, according to the AG.

As part of the settlement agreement, Synthes will:

  • Prohibit compensation of clinical investigators tied to the outcome of the clinical trial
  • Pay clinical investigators fair market value compensation for their clinical trial and consulting work
  • Collect information on financial interests from clinical investigators
  • Record all financial interests related to clinical investigators in a financial interest information database
  • Disclose all financial interests of all clinical investigators on the company’s Web site
  • Provide complete disclosure of financial interests to the FDA
  • Disclose all financial interests directly to healthcare facilities serving as clinical trial sites
  • Train employees on financial interest and disclosure

Pharmaceutical Industry

Read the latest on litigation affecting pharmaceutical manufacturers, as well as updates on proposed or pending changes to current law, and other developments in the industry with our up-to-the-minute pharmaceutical news alerts.
Read Alerts »

Medical Device Industry

Keep on top of all the happenings in the medical device industry, with news on recent government enforcement actions, product recalls and developments, and analysis of recent or proposed regulations with our updated medical device alerts.
Read Alerts »